OTCPK:MDRM

Stock Analysis Report

Executive Summary

Modern Mobility Aids, Inc. does not have significant operations.

Snowflake

Fundamentals

Adequate balance sheet with weak fundamentals.

Risks

  • Modern Mobility Aids has significant price volatility in the past 3 months.
  • Modern Mobility Aids's last earnings update was 1267 days ago.
  • Modern Mobility Aids is not covered by any analysts.

Share Price & News

How has Modern Mobility Aids's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

5.5%

MDRM

0.008%

US Healthcare

-0.2%

US Market


1 Year Return

-78.5%

MDRM

-9.0%

US Healthcare

1.1%

US Market

MDRM underperformed the Healthcare industry which returned -9.4% over the past year.

MDRM underperformed the Market in United States of America which returned 1.6% over the past year.


Share holder returns

MDRMIndustryMarket
7 Day5.5%0.008%-0.2%
30 Day-21.6%-0.8%2.5%
90 Day16.0%-1.5%1.6%
1 Year-78.5%-78.5%-7.6%-9.0%3.4%1.1%
3 Year-73.3%-73.3%29.6%24.4%45.2%35.8%
5 Year-87.1%-87.1%66.2%56.2%62.6%44.8%

Price Volatility Vs. Market

How volatile is Modern Mobility Aids's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Modern Mobility Aids undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether Modern Mobility Aids is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Modern Mobility Aids has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Examine Modern Mobility Aids's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Modern Mobility Aids regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Modern Mobility Aids expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

10.9%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Modern Mobility Aids has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Modern Mobility Aids performed over the past 5 years?

0.1%

Historical Healthcare annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Modern Mobility Aids has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

Financial Health

How is Modern Mobility Aids's financial position?


In this section we usually analyse Modern Mobility Aids's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Modern Mobility Aids has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of MDRM’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when Modern Mobility Aids's financial data was last updated here.
  • Explore more healthy companies in the Healthcare industry.

Dividend

What is Modern Mobility Aids's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Modern Mobility Aids's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Modern Mobility Aids's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Modern Mobility Aids has not reported any payouts.

Unable to verify if Modern Mobility Aids's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Modern Mobility Aids has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Modern Mobility Aids's salary, the management and board of directors tenure and is there insider trading?

2.6yrs

Average board tenure


CEO

Tito DiMarco 0

2.6yrs

Tenure

0

Mr. Tito DiMarco has been Chief Executive Officer, President and Director at Modern Mobility Aids, Inc. since February 28, 2017. Mr. DiMarco has been the President of Osvaldo Inc. since 2001. He has been e ...


Board Age and Tenure

2.6yrs

Average Tenure

The average tenure for the Modern Mobility Aids board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Management Team

  • Gilbert Sharpe

    Executive Advisor

    • Tenure: 2.6yrs
  • Tito DiMarco

    Chief Executive Officer

    • Tenure: 2.6yrs

Board Members

  • Peter Rothbart (80yo)

    Member of Medical Advisory Team

    • Tenure: 5.5yrs
  • Gilbert Sharpe

    Executive Advisor

    • Tenure: 2.6yrs
  • Tito DiMarco

    Chief Executive Officer

    • Tenure: 2.6yrs
  • Duncan Scott

    Director

    • Tenure: 0yrs

Company Information

Modern Mobility Aids, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Modern Mobility Aids, Inc.
  • Ticker: MDRM
  • Exchange: OTCPK
  • Founded: 2007
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: US$1.096m
  • Shares outstanding: 189.05m
  • Website: https://www.galileolife.com

Location

  • Modern Mobility Aids, Inc.
  • First Canadian Place
  • Suite 350
  • Toronto
  • Ontario
  • M5X 1C1
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MDRMOTCPK (Pink Sheets LLC)YesCommon StockUSUSDDec 2010

Biography

Modern Mobility Aids, Inc. does not have significant operations. The company focuses on the production and distribution of medical marijuana in North America. Previously, it was engaged in the distribution ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/20 00:54
End of Day Share Price2019/09/18 00:00
Earnings2015/03/31
Annual Earnings2014/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.